Ebola is a viral disease. A glycoprotein on the surface of the Ebola virus binds to a receptor protein found in the cell-surface membranes of human cells. The binding of the virus glycoprotein with the human cell receptor protein allows the virus to enter the cell. However, not all humans produce this receptor protein.
Those who don't have the receptor protein can still become infected with the virus, without actually developing the disease.
A blood test can be used to check whether a patient has the Ebola disease. The blood of patients with the disease contains large numbers of specific plasma cells and large numbers of a particular antibody. It has been suggested by researchers that patients with Ebola could be treated by giving them blood plasma transfusions from patients who have recently had the disease but have now recovered.
Researchers have also stated that the high mutation rate of the Ebola virus presents a challenge to the development of a vaccine.
Use the information provided above and your own knowledge to answer the following questions.
Explain how people who don't have the receptor protein in the surface membranes of their cells can still become infected with the virus, without actually developing the disease (lines 5-6).
Researchers found that the blood of patients who have Ebola contains large numbers of specific plasma cells and large numbers of a particular antibody (lines 7-9). Explain why this was the case.
The high mutation rates of viruses is problematic for developing vaccines against them (lines 13-14)
(i) Explain how a mutation could cause the antigen(s) on a virus to change.
(ii) Why is antigenic variation in a particular virus problematic for developing a vaccine?
It has been suggested by researchers that patients with Ebola could be treated by giving them blood plasma transfusions from patients who have recently had the disease but have now recovered (lines 9-12).
(i) Explain how these blood transfusions could be an effective treatment
(ii) Give one reason why the blood plasma should be tested before being given to Ebola patients.
Did this page help you?